瘤微环境中的CD8+ T细胞中的代谢检查点:综合性审查和新兴见解
Jiaqi Ai1, Yiheng Du1, Qianqian Xue1
1Department of Respiratory and Critical Care Medicine, Union Hospital, Tongii Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
International journal of biological sciences
|February 16, 2026
概括
癌症是一种代谢性疾病,CD8+ T细胞对于抗瘤免疫至关重要. 它们的新陈代谢受营养和检查点的影响,决定了免疫反应和治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢研究研究 代谢研究
背景情况:
- 癌症越来越被认为是一种代谢性疾病.
- 瘤微环境 (TME) 内的代谢重编程会影响瘤的发展.
- CD8+ T细胞是抗瘤免疫的关键调解者,经历了代谢变化.
研究的目的:
- 审查TME中CD8+T细胞的抗瘤功能和代谢概况.
- 阐明关键代谢物和代谢检查点在CD8+T细胞分化和功能中的作用.
- 探索针对癌症免疫治疗的代谢检查点的临床应用.
主要方法:
- 文献综述侧重于TME中CD8+T细胞代谢.
- 分析CD8+T细胞中的营养代谢 (葡萄糖,脂质,氨基酸).
- 讨论代谢检查点及其对T细胞的表观遗传影响.
主要成果:
- 在TME中,CD8+ T细胞在不同的分化阶段表现出不同的代谢特征.
- 代谢物和代谢检查点显著影响CD8+T细胞分化,效应器功能和免疫反应.
- 代谢检查点的影响存在异质性,这表明了量身定制的治疗策略.
结论:
- 代谢重编程是CD8+T细胞介导的抗瘤免疫的一个关键因素.
- 了解CD8+T细胞代谢为新的癌症免疫治疗策略提供了潜力.
- 准代谢检查点可能会提高基于T细胞的癌症治疗的疗效.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K


